Heterocyclics Inc., USA, is the Sales and Marketing Division of our manufacturing unit Dr. Jagath Reddy's Heterocyclics, which is located in India. Dr. Jagath Reddy's Heterocyclics, established in 1997, is on the move generating novel ideas and synthesizing new molecular entities. It's main activity is concentrated on developing building blocks with multi point reactivity which can serve as common core for library synthesis. It is also engaged in the cost effective production of rare & specialty chemicals.